ID

36678

Description

Anticancer Activity of Nicotinamide on Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02416739

Lien

https://clinicaltrials.gov/show/NCT02416739

Mots-clés

Versions (1)
  1. 31/05/2019 31/05/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

31 mai 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Small-Cell Lung Carcinoma NCT02416739

Anglais

Eligibility Non-Small-Cell Lung Carcinoma NCT02416739

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
operation-impossible stage 4 non-small-cell lung carcinoma (nsclc), or recurred terminal stage nsclc after previous operation or radiation therapy
Description

Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging | Non-small cell lung cancer recurrent End-stage | Status post Operative Surgical Procedures | Status post Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0278517
UMLS CUI [2,2]
C0205088
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0543467
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C1522449
egfr mutated (exon 19 deletion or l858r mutation)
Description

EGFR mutation | EGFR Exon 19 Deletion Mutation | Point mutation in exon 21 (L858R)

Type de données

boolean

Alias
UMLS CUI [1]
C3266992
UMLS CUI [2]
C4289657
UMLS CUI [3]
C3888903
life expectation more than 3 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
more than 1 measurable lesions by recist 1.1 which were not exposed to radiation previously
Description

Measurable lesion Quantity | Absence Exposure to Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C1522449
ecog (eastern cooperative oncology group ) performance status grade 0~2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
who signed the informed consent form
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
who had received chemotherapy or egfr tyrosin kinase inhibitors previously, except whom had received operation at least 6 months ago and received supplementary chemotherapy
Description

Prior Chemotherapy | EGFR TKI | Exception Operative Surgical Procedures | Exception Prior adjuvant chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C1443775
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0543467
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0281265
who has metastasized brain lesion that needs operation or radiation therapy
Description

Metastatic malignant neoplasm to brain Requirement Operative Surgical Procedures | Metastatic malignant neoplasm to brain Requirement Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0543467
UMLS CUI [2,1]
C0220650
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C1522449
above grade 2, ctcae (common toxicity criteria for adverse effects) 4.0 criteria for blood, liver and kidney
Description

Criteria hematologic CTCAE Grades | Criteria hepatic CTCAE Grades | Criteria renal CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0205488
UMLS CUI [1,3]
C1516728
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C0205054
UMLS CUI [2,3]
C1516728
UMLS CUI [3,1]
C0243161
UMLS CUI [3,2]
C0022646
UMLS CUI [3,3]
C1516728
who does not agree to contraception
Description

Contraceptive methods Unwilling

Type de données

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0558080
who has allergy to nicotinamide
Description

Niacinamide allergy

Type de données

boolean

Alias
UMLS CUI [1]
C0571839
Retour au début de la page

Similar models

Eligibility Non-Small-Cell Lung Carcinoma NCT02416739

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging | Non-small cell lung cancer recurrent End-stage | Status post Operative Surgical Procedures | Status post Therapeutic radiology procedure
Item
operation-impossible stage 4 non-small-cell lung carcinoma (nsclc), or recurred terminal stage nsclc after previous operation or radiation therapy
boolean
C0007131 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0278517 (UMLS CUI [2,1])
C0205088 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C1522449 (UMLS CUI [4,2])
EGFR mutation | EGFR Exon 19 Deletion Mutation | Point mutation in exon 21 (L858R)
Item
egfr mutated (exon 19 deletion or l858r mutation)
boolean
C3266992 (UMLS CUI [1])
C4289657 (UMLS CUI [2])
C3888903 (UMLS CUI [3])
Life Expectancy
Item
life expectation more than 3 months
boolean
C0023671 (UMLS CUI [1])
Measurable lesion Quantity | Absence Exposure to Therapeutic radiology procedure
Item
more than 1 measurable lesions by recist 1.1 which were not exposed to radiation previously
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
ECOG performance status
Item
ecog (eastern cooperative oncology group ) performance status grade 0~2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
who signed the informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | EGFR TKI | Exception Operative Surgical Procedures | Exception Prior adjuvant chemotherapy
Item
who had received chemotherapy or egfr tyrosin kinase inhibitors previously, except whom had received operation at least 6 months ago and received supplementary chemotherapy
boolean
C1514457 (UMLS CUI [1])
C1443775 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0281265 (UMLS CUI [4,2])
Metastatic malignant neoplasm to brain Requirement Operative Surgical Procedures | Metastatic malignant neoplasm to brain Requirement Therapeutic radiology procedure
Item
who has metastasized brain lesion that needs operation or radiation therapy
boolean
C0220650 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,3])
C0220650 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
Criteria hematologic CTCAE Grades | Criteria hepatic CTCAE Grades | Criteria renal CTCAE Grades
Item
above grade 2, ctcae (common toxicity criteria for adverse effects) 4.0 criteria for blood, liver and kidney
boolean
C0243161 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0243161 (UMLS CUI [2,1])
C0205054 (UMLS CUI [2,2])
C1516728 (UMLS CUI [2,3])
C0243161 (UMLS CUI [3,1])
C0022646 (UMLS CUI [3,2])
C1516728 (UMLS CUI [3,3])
Contraceptive methods Unwilling
Item
who does not agree to contraception
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
Niacinamide allergy
Item
who has allergy to nicotinamide
boolean
C0571839 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial